2m 2m 2m 2m 2m 2m 2m
Exozymes (EXOZ)
NASDAQ
$9.66+$0.16 (+1.68%)
Price as of Jun 03, 2026 4:10 PM EDT- $83.5MMarket Cap
- -32.96%1-Year Change
- BiotechnologyIndustry
Exozymes (EXOZ)
$9.66+$0.16 (+1.68%)
EXOZ | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.50 | ||
Change | -$0.17 (-1.76%) | ||
Open | $9.44 | ||
High | $9.71 | ||
Low | $9.38 | ||
Previous Close | $9.67 | ||
Volume | 8,060 | ||
30-Day Average Volume | 3,359 | ||
1-Week Change | -4.14% | ||
1-Month Change | -2.56% | ||
1-Year Change | -32.96% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 8.5M | ||
Total Assets | $4.0M | ||
Market Cap | $83.5M | ||
Enterprise Value | $82.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$1.6M | ||
EBIT | $0.00 | ||
EBITDA | $74,147.00 | ||
Net Working Capital | $507,585.00 | ||
EPS | -$0.28 | ||
Enterprise Value/EBITDA | 1,106 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 55 | ||
P/E | -35 | ||
PEG | N/A | ||
Price/Free Cash Flow | -53 | ||
Price/Operating Cash Flow | -55 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue